The Long, Winding Road of Immunotherapy Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Tag: Clinical Cancer Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
You’re working away on your latest project when your stomach suddenly growls. Stepping away from your desk, you head...
Editor’s note: This post was written by Nicholas Warren, PhD, science policy program administrator in the AACR’s Office of...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
New imaging system can help surgeons get more cancer out; Presurgery chemo can make ovarian cancer responsive to immunotherapy...
Researchers have well established that smoking leads to adverse outcomes in cancer patients; however, the specific effects caused by...